# Ciprofloxacin

NDC: 69117-0008
Generic name: Ciprofloxacin Tablets
Labeler / Manufacturer: Yiling Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20190713

FDA application: ANDA208921

## Active ingredients

- CIPROFLOXACIN HYDROCHLORIDE: 250 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69117-0008"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69117-0008
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fd3da0b-7428-ac8f-e053-2a91aa0aed9f